INTEROBSERVER RELIABILITY BETWEEN NEUROLOGISTS IN TRAINING OF PARKINSONS-DISEASE RATING-SCALES - A MULTICENTER STUDY

被引：46

作者：

GEMINIANI, G

CESANA, BM

TAMMA, F

CONTRI, P

PACCHETTI, C

CARELLA, F

PIOLTI, R

MARTIGNONI, E

GIOVANNINI, P

GIROTTI, F

CARACENI, T

机构：

[1] Istituto Nazionale Neurologico, Milan

[2] Epidemiologic Laboratory, Ospedale Maggiore I.R.C.C.S, Milan

[3] Department of Neurology, Ospedale S. Gerardo, Monza

[4] Department of Neurology, Ospedale Sacco, Milan

[5] Istituto Neurologico "C. Mondino, Pavia

来源：

MOVEMENT DISORDERS | 1991年 / 6卷 / 04期

关键词：

PARKINSONS DISEASE; RATING SCALE; RELIABILITY;

D O I：

10.1002/mds.870060411

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A multicenter study has been conducted to determine the interobserver reproducibility of four of the most frequently used rating scales for Parkinson's disease: the Columbia University Rating Scale (CURS) and the Webster Rating Scale (WRS), both for assessing clinical signs; the Northwestern University Disability Scale (NUDS); and the Hoehn and Yahr staging. Four resident neurologists, inexperienced in the use of the four scales, independently examined 48 parkinsonian patients. The extent to which their assessments agreed was determined by calculating the Cohen k index after the scores had been recodified. The physicians' scores agreed substantially for the CURS and the Hoehn and Yahr scale, while those for the NUDS and the WRS agreed only moderately. Analysis of individual item scores within the scales suggests improvements that would offer greater interobserver consistency.

引用

页码：330 / 335

页数：6

共 18 条

[1]

Larsen TA, LeWitt PA, Calne DB., Theoretical and practical issues in assessment of deficits and therapy in parkinsonism, Lisuride and other dopamine agonists, pp. 363-373, (1983)

[2]

Duvoisin RC., The evaluation of extrapyramidal disease, Monoamines noyaux gris centraux et syndrome de Parkinson, pp. 313-325, (1971)

[3]

Webster DD., Critical analysis of the disability in Parkinson's disease, Mod Treat, 5, pp. 257-282, (1968)

[4]

Markham CH., The choreoathetoid movement disorder induced by levodopa, Clin Pharmacol Ther, 12, pp. 340-343, (1971)

[5]

Lieberman A., Parkinson's disease: a clinical review, Am J Med Sci, 277, pp. 66-80, (1974)

[6]

Parkes JD, Zilkha KJ, Calver DM, Knill-Jones RP., Controlled trial of amantadine hydrochloride in Parkinson's disease, Lancet, 1, pp. 259-262, (1970)

[7]

Canter GJ, De La Torre R, Mier M., A method for evaluating disability in patients with Parkinson's disease, J Nerv Ment Dis, 133, pp. 143-147, (1961)

[8]

England AC, Schwab RS., Post‐operative evaluation of selected patients with Parkinson's disease, J Am Geriatr Soc, 4, pp. 1219-1232, (1956)

[9]

Hoehn MM, Yahr MD., Parkinsonism: onset, progression and mortality, Neurology, 17, pp. 427-442, (1967)

[10]

Fahn S, Elton RL, Members of the UPDRS Development Committe. The Unified Parkinson's Disease Rating Scale, Recent developments in Parkinson's disease, 2, pp. 153-163, (1987)

← 1 2 →